New Post-Glaucoma Treatment Trialled


A new treatment that could reduce retinal scarring in people who have undergone surgery to correct glaucoma is currently being trialled. Manufacturers Promedior Inc. claim, if approved, the treatment would be the first anti-fibrotic drug therapy licensed to treat a fibrotic eye disease and the first available, in both America and Europe, to remedy post-surgical scarring in glaucoma patients.

Experts explain that post-surgical scarring is an unfortunate occurrence that can seriously diminish the vision improving results achieved by surgery used to correct glaucoma or high levels of intraocular eye pressure.

Glaucoma is one of the leading causes of blindness worldwide. Researchers hope that the treatment could eventually be used to help better treat and further improve the vision of patients who have undergone surgery to halt the damage done to their vision by the progressively blinding eye disease.

9th September 2010

<<<more glaucoma news


Laser Eye Surgery Enquiry Form

Complete this form if you would like information about laser eye surgery including costs & suitablity.